Report cover image

Pharmaceutical Intermediates Global Market Opportunities And Strategies To 2033

Publisher The Business Research Company
Published Mar 19, 2024
Length 326 Pages
SKU # BRC18636747

Description

Pharmaceutical Intermediates Global Market Opportunities And Strategies To 2033

Including: 1) By Product: Chemical Intermediate; Bulk Drug Intermediate2) By Category: Branded Drug Intermediate; Generic Drug Intermediate3) By Application: Oncology Drugs; Anti-Infective Drugs; Central Nervous System Drugs; Respiratory Diseases Drugs; Cardiovascular Drugs; Musculoskeletal Disorders Drugs; Metabolic Disorders Drugs4) By End-User: Biotech And Pharma Companies; Research InstitutionsCovering: BASF SE; Evonik Industries AG; Pfizer Inc.; Arkema Inc.; Koninklijke DSM N.V.


Pharmaceutical Intermediates Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global pharmaceutical intermediates market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Description:

Where is the largest and fastest-growing market for pharmaceutical intermediates? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The pharmaceutical intermediates market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider pharmaceutical intermediates market; and compares it with other markets.

The report covers the following chapters
  • Introduction And Market Characteristics
Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by category, by application and by end-user.
  • Key Trends
Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario
The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the pharmaceutical intermediates market.
  • Global Market Size And Growth
Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis
Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation
Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, segmentation by category, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth
Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape
Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies
Details on the company profiles of other major and innovative companies
  • Competitive Benchmarking
Briefs on the financials comparison between major players in the market
  • Competitive Dashboard
Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions
Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies
Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations
This section includes recommendations for the pharmaceutical intermediates providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix
This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

1) By Product: Chemical Intermediate; Bulk Drug Intermediate; Other Products

2) By Category: Branded Drug Intermediate; Generic Drug Intermediate

3) By Application: Oncology Drugs; Anti-Infective Drugs; Central Nervous System Drugs; Respiratory Diseases Drugs; Cardiovascular Drugs; Musculoskeletal Disorders Drugs; Metabolic Disorders Drugs; Other Applications

4) By End-User: Biotech And Pharma Companies; Research Institutions; Other End-Users

Companies Mentioned: BASF SE; Evonik Industries AG; Pfizer Inc; Arkema Inc; Koninklijke DSM N.V.

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; pharmaceutical intermediates indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

326 Pages
1 Executive Summary
1.1 Pharmaceutical Intermediates – Market Attractiveness And Macro economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Pharmaceutical Intermediates Market Definition And Segmentations
6.4 Market Segmentation By Product
6.4.1 Chemical Intermediate
6.4.2 Bulk Drug Intermediate
6.4.3 Other Products
6.5 Market Segmentation By Category
6.5.1 Branded Drug Intermediate
6.5.2 Generic Drug Intermediate
6.6 Market Segmentation By Application
6.6.1 Oncology Drugs
6.6.2 Anti-Infective Drugs
6.6.3 Central Nervous System Drugs
6.6.4 Respiratory Diseases Drugs
6.6.5 Cardiovascular Drugs
6.6.6 Musculoskeletal Disorders Drugs
6.6.7 Metabolic Disorders Drugs
6.6.8 Other Applications
6.7 Market Segmentation By End-User
6.7.1 Biotech And Pharma Companies
6.7.2 Research Institutions
6.7.3 Other End-Users
7 Major Market Trends
7.1 Innovative AI Solutions For Seamless Integration Of Drug Discovery And Synthesis
7.2 Strategic Partnerships And Acquisitions Among Market Players To Drive Innovation In The Market
7.3 Innovative Product Launches To Support The Evolution Of Safe And Effective Medicines
7.4 Focus On Production Facility Expansions
7.5 Quick Response (QR) Code Labelling To Track All Drug-Related Information
7.6 Focus On Green Chemistry To Reduce The Environmental Impact Of Synthetic Chemistry
8 Pharmaceutical Intermediates Market - Macro Economic Scenario
8.1 COVID-19 Impact On The Pharmaceutical Intermediates Market
8.2 Impact Of The War In Ukraine On The Pharmaceutical Intermediates Market
8.3 Impact Of High Inflation On The Pharmaceutical Intermediates Market
9 Global Market Size and Growth
9.1 Market Size
9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)
9.2.1 Market Drivers 2018 – 2023
9.2.2 Market Restraints 2018 – 2023
9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million)
9.3.1 Market Drivers 2023 – 2028
9.3.2 Market Restraints 2023 – 2028
10 Global Pharmaceutical Intermediates Market Segmentation
10.1 Global Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
10.2 Global Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
10.3 Global Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
10.4 Global Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
11 Pharmaceutical Intermediates Market, Regional and Country Analysis
11.1 Global Pharmaceutical Intermediates Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
11.2 Global Pharmaceutical Intermediates Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12 Asia-Pacific Market
12.1 Summary
12.2 Market Overview
12.2.1 Region Information
12.2.2 Market Information
12.2.3 Background Information
12.2.4 Government Initiatives
12.2.5 Regulations
12.2.6 Regulatory Bodies
12.2.7 Major Associations
12.2.8 Taxes Levied
12.2.9 Corporate Tax Structure
12.2.10 Investments
12.2.11 Major Companies
12.3 Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.6 Asia-Pacific Pharmaceutical Intermediates Market: Country Analysis
12.7 China Market
12.8 Summary
12.9 Market Overview
12.9.1 Country Information
12.9.2 Market Information
12.9.3 Background Information
12.9.4 Government Initiatives
12.9.5 Regulations
12.9.6 Regulatory Bodies
12.9.7 Major Associations
12.9.8 Taxes Levied
12.9.9 Corporate Tax Structure
12.9.10 Investments
12.9.11 Major Companies
12.10 China Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.11 China Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.12 China Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.13 India Market
12.14 India Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.15 India Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.16 India Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.17 Japan Market
12.18 Japan Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.19 Japan Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.20 Japan Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.21 Australia Market
12.22 Australia Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.23 Australia Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.24 Australia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia Market
12.26 Indonesia Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.27 Indonesia Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.28 Indonesia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea Market
12.30 South Korea Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.31 South Korea Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.32 South Korea Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13 Western Europe Market
13.1 Summary
13.2 Market Overview
13.2.1 Region Information
13.2.2 Market Information
13.2.3 Background Information
13.2.4 Government Initiatives
13.2.5 Regulations
13.2.6 Regulatory Bodies
13.2.7 Major Associations
13.2.8 Taxes Levied
13.2.9 Corporate Tax Structure
13.2.10 Investments
13.2.11 Major Companies
13.3 Western Europe Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.6 Western Europe Pharmaceutical Intermediates Market: Country Analysis
13.7 UK Market
13.8 UK Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.9 UK Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.10 UK Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.11 Germany Market
13.12 Germany Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.13 Germany Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.14 Germany Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.15 France Market
13.16 France Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.17 France Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.18 France Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.19 Italy Market
13.20 Italy Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.21 Italy Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.22 Italy Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.23 Spain Market
13.24 Spain Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.25 Spain Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.26 Spain Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14 Eastern Europe Market
14.1 Summary
14.2 Market Overview
14.2.1 Region Information
14.2.2 Market Information
14.2.3 Background Information
14.2.4 Government Initiatives
14.2.5 Regulations
14.2.6 Regulatory Bodies
14.2.7 Major Associations
14.2.8 Taxes Levied
14.2.9 Corporate Tax Structure
14.2.10 Investments
14.2.11 Major Companies
14.3 Eastern Europe Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.6 Eastern Europe Pharmaceutical Intermediates Market: Country Analysis
14.7 Russia Market
14.8 Russia Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.10 Russia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15 North America Market
15.1 Summary
15.2 Market Overview
15.2.1 Region Information
15.2.2 Market Information
15.2.3 Background Information
15.2.4 Government Initiatives
15.2.5 Regulations
15.2.6 Regulatory Bodies
15.2.7 Major Associations
15.2.8 Taxes Levied
15.2.9 Corporate Tax Structure
15.2.10 Investments
15.2.11 Major Companies
15.3 North America Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.4 North America Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.5 North America Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.6 North America Pharmaceutical Intermediates Market: Country Analysis
15.7 USA Market
15.8 Summary
15.9 Market Overview
15.9.1 Country Information
15.9.2 Market Information
15.9.3 Background Information
15.9.4 Government Initiatives
15.9.5 Regulations
15.9.6 Regulatory Bodies
15.9.7 Major Associations
15.9.8 Taxes Levied
15.9.9 Corporate Tax Structure
15.9.10 Investments
15.9.11 Major Companies
15.10 USA Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.11 USA Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.12 USA Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.13 Canada Market
15.14 Canada Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.15 Canada Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.16 Canada Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16 South America Market
16.1 Summary
16.2 Market Overview
16.2.1 Region Information
16.2.2 Market Information
16.2.3 Background Information
16.2.4 Government Initiatives
16.2.5 Regulations
16.2.6 Regulatory Bodies
16.2.7 Major Associations
16.2.8 Taxes Levied
16.2.9 Corporate Tax Structure
16.2.10 Investments
16.2.11 Major Companies
16.3 South America Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.4 South America Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.5 South America Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.6 South America Pharmaceutical Intermediates Market: Country Analysis
16.7 Brazil Market
16.8 Brazil Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.10 Brazil Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
17 Middle East Market
17.1 Summary
17.2 Market Overview
17.2.1 Region Information
17.2.2 Market Information
17.2.3 Background Information
17.2.4 Government Initiatives
17.2.5 Regulations
17.2.6 Regulatory Bodies
17.2.7 Major Associations
17.2.8 Taxes Levied
17.2.9 Corporate Tax Structure
17.2.10 Investments
17.2.11 Major Companies
17.3 Middle East Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
17.5 Middle East Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
18 Africa Market
18.1 Summary
18.2 Market Overview
18.2.1 Region Information
18.2.2 Market Information
18.2.3 Background Information
18.2.4 Government Initiatives
18.2.5 Regulations
18.2.6 Regulatory Bodies
18.2.7 Major Associations
18.2.8 Taxes Levied
18.2.9 Corporate Tax Structure
18.2.10 Investments
18.2.11 Major Companies
18.3 Africa Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
18.5 Africa Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
19 Competitive Landscape and Company Profiles
19.1 Company Profiles
19.2 BASF SE
19.2.1 Company Overview
19.2.2 Products And Services
19.2.3 Business Strategy
19.2.4 Financial Overview
19.3 Evonik Industries AG
19.3.1 Company Overview
19.3.2 Products And Services
19.3.3 Business Strategy
19.3.4 Financial Overview
19.4 Pfizer Inc
19.4.1 Company Overview
19.4.2 Products And Services
19.4.3 Business Strategy
19.4.4 Financial Overview
19.5 Arkema S.A.
19.5.1 Company Overview
19.5.2 Products And Services
19.5.3 Business Strategy
19.5.4 Financial Overview
19.6 Koninklijke DSM N.V.
19.6.1 Company Overview
19.6.2 Products And Services
19.6.3 Business Strategy
19.6.4 Financial performance
20 Other Major And Innovative Companies
20.1 Cambrex Corporation
20.1.1 Company Overview
20.1.2 Products And Services
20.1.3 Business Strategy
20.2 Lianhe Chemical Technology Co Ltd
20.2.1 Company Overview
20.2.2 Products And Services
20.3 Ercros, S.A.
20.3.1 Company Overview
20.3.2 Products And Services
20.3.3 Business Strategy
20.4 Lonza Group AG
20.4.1 Company Overview
20.4.2 Products And Services
20.4.3 1.4.3 Business Strategy
20.5 Codexis, Inc
20.5.1 Company Overview
20.5.2 Products And Services
20.5.3 Business Strategy
20.6 Actylis
20.6.1 Company Overview
20.6.2 Products And Services
20.6.3 Business Strategy
20.7 Kuraray Co., Ltd
20.7.1 Company Overview
20.7.2 Products And Services
20.8 Vertellus Holdings LLC
20.8.1 Company Overview
20.8.2 Products And Services
20.9 Hikal Ltd
20.9.1 Company Overview
20.9.2 Products And Services
20.10 WeylChem International GmbH
20.10.1 Company Overview
20.10.2 Products And Services
20.10.3 Business Strategy
21 Competitive Benchmarking
22 Competitive Dashboard
23 Key Mergers And Acquisitions
23.1 Hovione Acquired ExtremoChem
23.2 Noramco Acquired The Cambrex Drug Product Business Unit
23.3 Harmony Biosciences Acquired Zynerba Pharmaceuticals
23.4 UBE Acquired API Corporation
23.5 Cambrex Acquired Snapdragon Chemistry
23.6 Sekhmet Pharmaventures Acquired Optimus Drugs
23.7 SK Capital Partners Acquired A Majority Shareholding Of SEQENS
23.8 Aceto Corporation Acquired Cascade Chemistry
23.9 Wavelength Pharmaceuticals Acquired Vanamali Organics
24 Opportunities And Strategies
24.1 Global Pharmaceutical Intermediates Market In 2028 – Countries Offering Most New Opportunities
24.2 Global Pharmaceutical Intermediates Market In 2028 – Segments Offering Most New Opportunities
24.3 Global Pharmaceutical Intermediates Market In 2028 – Growth Strategies
24.3.1 Market Trend Based Strategies
24.3.2 Competitor Strategies
25 Pharmaceutical Intermediates Market, Conclusions And Recommendations
25.1 Conclusions
25.2 Recommendations
25.2.1 Product
25.2.2 Place
25.2.3 Price
25.2.4 Promotion
25.2.5 People
26 Appendix
26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us